Results 61 to 70 of about 199,951 (284)
Anti-beta 2-glycoprotein I antibodies in a patient with catastrophic antphospholipid syndrome. [PDF]
, 1995 IF: 0,559 Autoimmune antiphospholipid antibodies are a hallmark of patients with antiphospholipid syndrome, and require a protein cofactor, beta 2-glycoprotein I, to bind anionic phospholipids. In these same patients, moreover, IgG directly binding beta
PENGO, VITTORIO +3 more
core
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? [PDF]
, 1995 Anticardiolipin (aCL) and anti-beta(2)-glycoprotein I(anti beta 2GPI) antibodies have been shown in animal models as not cross-reacting antibody populations.
A. Tincani +8 more
core +1 more source
PharmaceuticalsBackground: The hunt for naturally occurring antiviral compounds to combat viral infection was expedited when COVID-19 and Ebola spread rapidly. Phytochemicals from Nyctanthes arbor-tristis Linn were evaluated as significant inhibitors of these viruses ...
Raed Albiheyri +4 more
doaj +1 more source
3005 Integrin Mac-1 Potentiates Neutrophil Adhesion and NET Release in Antiphospholipid Syndrome
Journal of Clinical and Translational Science, 2019 OBJECTIVES/SPECIFIC AIMS: While the role of antiphospholipid antibodies in activating endothelial cells has been extensively studied, the impact of these antibodies on the adhesive potential of leukocytes has received considerably less attention.
Gautam Sule +4 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the diagnostic accuracy of glial fibrillary acidic protein (GFAP) measured in dried plasma spots versus conventional plasma‐ and serum‐GFAP testing for assessment of disease severity in aquaporin‐4 immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4‐IgG+ NMOSD).
Felix Wohlrab +19 more
wiley +1 more source
Diagnosis of antiphospholipid syndrome in routine clinical practice. [PDF]
, 2013 The updated international consensus criteria for definite antiphospholipid syndrome (APS) are useful for scientific clinical studies. However, there remains a need for diagnostic criteria for routine clinical use.
Hills, J +3 more
core
Conformationally altered beta(2)-glycoprotein I is the antigen for anti-cardiolipin autoantibodies [PDF]
, 1999 Anti-cardiolipin autoantibodies (aCL) induce thrombosis and recurrent fetal death. These antibodies require a 'cofactor', identified as beta(2)-glycoprotein I (beta(2)-GPI), to bind phospholipids. We show here that aCL can bind beta(2)-GPI in the absence
Johnson, P.M. +4 more
core +1 more source
Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome [PDF]
, 2020 Antiphospholipid syndrome (APS) affects coagulation and the brain by autoimmune mechanisms. The major antigen in APS is beta-2-glycoprotein I (?2-GPI) is known to complex with annexin A2 (ANXA2), and antibodies to ANXA2 have been described in APS.
Weiss R. +7 more
core +1 more source
A Polymerase-chain-reaction Assay for the Specific Identification of Transcripts Encoded by Individual Carcinoembryonic Antigen (CEA)-gene-family Members [PDF]
, 1993 Carcinoembryonic antigen (CEA) is a tumor marker that belongs to a family of closely related molecules with variable expression patterns. We have developed sets of oligonucleotide primers for the specific amplification of transcripts from individual CEA ...
Zimmermann, Wolfgang +15 more
core +1 more source
Advances in Rheumatology, 2021 Background Antiphospholipid syndrome (APS) is characterized by episodes of thrombosis, obstetric morbidity or both, associated with persistently positive antiphospholipid antibodies (aPL).
Erivelton de Azevedo Lopes +25 more
doaj +1 more source